Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-05-02
2006-05-02
Padmanabhan, Sreeni (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S410000, C514S416000
Reexamination Certificate
active
07037901
ABSTRACT:
The present invention is based on the discovery of a composition that provides radiosensitization effect. Specifically the composition contains an indolocarbazole derivative. The present invention provides methods for radiosensitizing neoplastic cells using indolocarbazole derivatives and methods for treating neoplastic cells using indolocarbazole derivatives in combination with radiation or radiation and chemotherapy.
REFERENCES:
Prudhomme “Recent Developments of Rebeccamycin Analogues as Topoisomerase I inhibitors and Antitumor Agents” Current Medicinal Chemistry, 2000, 7, pp. 1189-1212.
Chen et al. “Mammalian DNA Topoisomerase I Mediates the Enhancement of Radiation Cytotoxicity by Campotothecin Derivatives” Cancer Research 57, pp. 1529-1536, Apr. 15, 1997.
Carter et al. Chemotherapy of Cancer, Second Edition. 1981. pp. 361-363, 365.
C. Bailly, et al., “The Camptothecin-Resistant Topoisomerase I Mutant F361S is Cross-Resistant to Antitumor Rebeccamycin Derivatives. A Model for Topoisomerase I Inhibition by Indolocarbazoles,” Biochemistry, vol. 38, pp. 8605-8611 (1999).
T. Yoshinari, et al., “Induction of Topoisomerase I-Mediated DNA Cleavage by a New Indolcarbazole, ED-110,” Cancer Res, vol. 53, pp. 490-494 (1990).
Christian Bailly, et al., “Recognition of Specific Sequences in DNA by a Topoisomerase I Inhibitor Derived from the Antitumor Drug Rebeccamycin,” Molecular Pharmacology, vol. 53, Issue 1, pp. 77-87 (1998).
Christian Bailly, et al., “Enhanced Binding to DNA and Topoisomerase I Inhibition by an Analog of the Antitumor Antibiotic Rebeccamycin Containing an Amino Sugar Residue,” Molecular Pharmacology, vol. 55, Issue 2, pp. 377-385 (1999).
E.R. Pereira, et al., “Structure-activity Relationships in a Series of Substituted Indolocarbazoles: Topoisomerase I and Protein Kinase C Inhibition and Antitumoral and Antimicrobial Properties,” J Med Chem, vol. 39, pp. 4471-4477 (1996).
Emmanuel Labourier, et al., “Poisoning of Topoisomerase I by an Antitumor Indolocarbazole Drug,” Cancer Research, vol. 59, pp. 52-55 (1999).
F. Anizon, et al., “Syntheses and Biological Activities (Topoisomerase Inhibition and Antitumor and Antimicrobial Properties) of Rebeccamycin Analogues Bearing Modified Sugar Moieties and Substituted on the Imide Nitrogen with a Methyl Group,” J Med Chem, vol. 40, pp. 3456-3465 (1997).
P. Moreau, et al., “Syntheses and Biological Evaluation of Indolocarbazoles, Analogues of Rebeccamycin, Modified at the Imide Heterocycle,” J Med Chem, vol. 41, pp. 1631-1640 (1998).
P. Moreau, et al., “Synthesis, Mode of Action, and Biological Activities of Rebeccamycin Bromo Derivatives,” J Med Chem, vol. 42, pp. 1816-1822 (1999).
A. Tanizawa, et al., “Topoisomerase I Alteration in a Camptothecin-Resistant Cell Line Derived from Chinese Hamster DC3F Cells in Culture,” Cancer Res, vol. 52, pp. 1848-1854 (1992).
A. Tanizawa, et al., “Cloning of Chinese Hamster DNA Topoisomerase I cDNA and Identification of a Single Point Mutation Responsible for Camptothecin Resistance,” J Biol Chem, vol. 268, pp. 25463-25468 (1993).
N. Albright, “Computer Programs for the Analysis of Cellular Survival Data,” Radiat Res, vol. 112, pp. 331-340 (1987).
YN Chen, et al., “Characterization of Adriamycin-Resistant Human Breast Cancer Cells which Display Overexpression of a Novel Resistance-Related Membrane Protein,” J Biol Chem, vol. 265, pp. 10073-10080 (1990).
D. Subramanian, et al., “Analysis of Topoisomerase I/DNA Complexes in Patients Administered Topotecan,” Cancer Res, vol. 55, pp. 2097-2103 (1995).
Corinne Pondarré, et al., “In vivo Sequencing of Camptothecin-Induced Topoisomerase I Cleavage Sites in Human Colon Carcinoma Cells,” Nucleic Acids Research, vol. 25, pp. 4111-4116 (1997).
L.L. Herscher, et al., “Principles of Chemoradiation: Theoretical and Practical Considerations,” Oncology (Huntingt), vol. 13, pp. 11-22 (1999).
Allan Y. Chen, et al., “p53 and p21 Are Major Cellular Determinants for DNA Topoisomerase I-Mediated Radiation Sensitization in Mammalian Cells,” Annals of the New York Academy of Sciences, vol. 922, pp. 298-300 (2000).
Zezhang T. Wen, et al., “Functional Genomics Approach to Identifying Genes Required to Biofilm Development byStreptococcus mutans,” Applied and Environmental Microbiology, vol. 68, No. 3, pp. 1196-1203 (2002).
Paul E. Kolenbrander, et al., “Intergeneric Coaggregation of OralTreponemaspp. WithFusobacteriumssp. And Intrageneric Coaggregation amongFusobacteriumspp.,” Infection and Immunity, vol. 63, No. 12, pp. 4584-4588 (1995).
Karsten R. O. Hazlett, et al., “Inactivation of thegbpAGene ofStreptococcus mutansAlters structural and Functional Aspects of Plaque Biofilm which are Compensated by Recombination of thegtfBandgtfCGenes,” Infection and Immunity, vol. 67, No. 8, pp. 3909-3914 (1999).
Renata O. Mattos-Graner, et al., “Cloning of theStreptococcus mutansGene Encoding Glucan Binding Protein B and Analysis of Genetic Diversity and Protein Production in Clinical Isolates,” Infection and Immunity, vol. 69, No. 11, pp. 6931-6941 (2001).
Leslie A. Pratt, et al., “Genetic Analyses of Bacterial Biofilm Formation,” Current Opinion in Microbiology, vol. 2, pp. 598-603 (1999).
Gary M. Dunny, et al., “Cell-Cell Communication in Gram-Positive Bacteria,” Annu. Rev. Microbiol., vol. 51, pp. 527-564 (1997).
Elizabeth A. Joyce, et al., “Evidence for a Signaling System inHelicobacter pylorf: Detection of aluxS-Encoded Autoinducer,” Journal of Bacteriology, vol. 182, No. 13, pp. 3638-3643 (2000).
Mark H. Forsyth, et al., “Intercellular Communication inHelicobacter pylort: luxSIs Essential for the Production of an Extracellular Signaling Molecule,” Infection and Immunity, vol. 68, No. 6, pp. 3193-3199 (2000).
S. N. Ruzheinikov, et al., The 1.2 A Structure of a Novel Quorum-Sensing Protein,Bacillus subtilisLuxS, J. Mol. Biol., vol. 313, pp. 111-122 (2001).
Stephan Schauder, et al., The LuxS Family of Bacterial Autoinducers: Biosynthesis of a Novel Quorum-Sensing Signal Molecule, Molecular Biology, vol. 41, Issue 2, pp. 463-476 (2001).
Michael G. Surette, et al., “Quorum Sensing inEscherichia coli, Salmonella typhimuruiumandVibrio harveyi: A New Family of Genes Responsible for Autoinducer Production,” Proc. Natl. Acad. Sci. USA, vol. 96, pp. 1639-1644 (1999).
Mary Ellen Davey, et al., “Microbial Biofilms: form Ecology to Molecular Genetics,” Microbiology and Molecular Biology Reviews, pp. 847-867 (2000).
Ping Chen, et al., “The Specific Genes for Lantibiotic Mutacin II Biosynthesis inStreptococcus mutansTB Are Clustered and Can Be Transferred En Bloc,” Applied and Environmental Microbiology, pp. 1356-1360 (1999).
Fengxia QI, et al., “Purification of Mutacin III from Group IIIStreptococcus mutansUA787 and Genetic Analyses of Mutacin III Biosynthesis Genes,” Applied and Environmental Microbiology, vol. 65, No. 9, pp. 3880-3887 (1999).
Kim Jennifer
Morgan & Lewis & Bockius, LLP
Padmanabhan Sreeni
University of California
LandOfFree
Radiosensitization by indolocarbazole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radiosensitization by indolocarbazole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiosensitization by indolocarbazole derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3633287